Literature DB >> 32132087

Ultrasound Assessment of Synchronous Thyroid Nodules in Patients With Papillary Thyroid Cancer: A Nodule-by-nodule Analysis Between Ultrasound and Pathology.

Hye Jung Kim1, Hui Joong Lee2, Jin Hyang Jung3, Wan Wook Kim3, Ji Young Park4, Kyung Min Shin1, Won Hwa Kim1, Seung Hyun Cho1.   

Abstract

BACKGROUND/AIM: The purpose of this study was to evaluate the diagnostic value of preoperative ultrasound (US) in the assessment of synchronous thyroid nodules in patients with papillary thyroid cancer (PTC) for determination of surgical extent. PATIENTS AND METHODS: A total of 210 consecutive patients who were surgically diagnosed with PTC were included in this study. Synchronous nodules, divided into probably benign and suspicious nodules based on US findings, were correlated with pathologic results using a nodule-by-nodule analysis.
RESULTS: Among the 302 synchronous nodules in 129 patients, 83 (27.5%) synchronous nodules in 73 patients were diagnosed as malignant after surgery. Ipsilateral probably benign nodules on US were more likely to be malignant than contralateral probably benign nodules (ipsilateral, 10.6%; contralateral, 2.0%, p=0.015). The presence of suspicious contralateral nodules on US and the number of synchronous nodules were significant factors related to contralateral cancer (p<0.001 and 0.030).
CONCLUSION: For evaluation of synchronous nodules in PTC patients, US assessment for synchronous nodules can be applied for preserving the contralateral lobe. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Thyroid cancer; papillary; thyroid nodule; ultrasonography

Year:  2020        PMID: 32132087     DOI: 10.21873/anticanres.14132

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  1 in total

1.  Ultrasound Echogenicity of Papillary Thyroid Cancer Is Affected by Tumor Growth Patterns and Tumor Fibrosis.

Authors:  Yun-Sung Lim; Yoon Se Lee; Jin-Choon Lee; Seok-Man Son; Dong-Hoon Shin; Sang Soo Kim; In-Ju Kim; Byung-Joo Lee
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.406

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.